Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|November 7, 2006
Role for neutral sphingomyelinase-2 in tumor necrosis factor alpha-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2Christopher J Clarke, Thach-Giao Truong, Yusuf A Hannun
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2021
Current Challenges in Access to Melanoma Care: A Multidisciplinary PerspectiveNikhil I Khushalani, Thach-Giao Truong, John F Thompson
The Permanente Journal|February 26, 2021
Immune-related Adverse Effects Associated with Programmed Death-1 Inhibitor Therapy in the Treatment of Non-Small Cell Lung Cancer: Incidence, Management, and Effect on OutcomesTimothy Chiu, Christopher Yamamoto, Fang Niu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 22, 2023
Outcomes of weight-based vs. fixed dose of Pembrolizumab among patients with non-small cell lung cancerLena Chaitesipaseut, Nina Shah, Thach-Giao Truong, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancerAndrew H Ko, Thach-Giao Truong, Emily Kantoff, et al.
Pigment Cell & Melanoma Research|March 5, 2025
Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline VariantsIsabella Ribaudo, Michelle Arbesman, Ying Ni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor MalignanciesRahul Aggarwal, Scott Thomas, Nela Pawlowska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2021
TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal CancerMinggui Pan, Chen Jiang, Pam Tse, et al.
JAMA Oncology|November 23, 2022
Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical TrialJoseph M Unger, Amy Darke, Megan Othus, et al.
JCO Oncology Practice|June 23, 2026
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 TherapyMegan Othus, Thach-Giao Truong, Elad Sharon, et al.
Pageof 2